Venture Investment and Partnership (VIP) Forum with Daiichi Sankyo

Life Science Washington hosts a Venture Investment and Partnership (VIP) Forum with pharmaceutical company Daiichi Sankyo for Washington life science companies and researchers. Attendees hear about Daiichi Sankyo’s areas of focus, investment approach and partnering priorities, followed by a panel with current Daiichi venture partners and a networking reception. The Oct. 27 session begins with registration at 2:45 p.m., with the program running from 3 p.m. and networking from 4:55 p.m. until 6:30 p.m. Registration is open to Life Science Washington members from life science companies and research institutions, not service providers. Register here